Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Background: Lynch syndrome (LS) is a cancer predisposition syndrome affecting more than 1 in every 300 individuals worldwide. Clinical genetic testing for LS can be life-saving but is complicated by the heavy burden of variants of uncertain significance (VUS), especially missense changes. Result: To address this challenge, we leverage a multiplexed analysis of variant effect (MAVE) map covering >94% of the 17,746 possible missense variants in the key LS gene MSH2 . To establish this map’s utility in large-scale variant reclassification, we overlay it on clinical databases of >15,000 individuals with LS gene variants uncovered during clinical genetic testing. We validate these functional measurements in a cohort of individuals with paired tumor-normal test results and find that MAVE-based function scores agree with the clinical interpretation for every one of the MSH2 missense variants with an available classification. We use these scores to attempt reclassification for 682 unique missense VUS, among which 34 scored as deleterious by our function map, in line with previously published rates for other cancer predisposition genes. Combining functional data and other evidence, ten missense VUS are reclassified as pathogenic/likely pathogenic, and another 497 could be moved to benign/likely benign. Finally, we apply these functional scores to paired tumor-normal genetic tests and identify a subset of patients with biallelic somatic loss of function, reflecting a sporadic Lynch-like Syndrome with distinct implications for treatment and relatives’ risk. Conclusion: This study demonstrates how high-throughput functional assays can empower scalable VUS resolution and prospectively generate strong evidence for variant classification.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Richards, S., Aziz, N., Bale, S., Bick, D., Das, S., Gastier-Foster, J., Grody, W. W., Hegde, M., Lyon, E., Spector, E., et al. (2015) · Genetics in Medicine · doi:10.1038/gim.2015.30 · Cited by 32,594
ClinVar: improving access to variant interpretations and supporting evidence
Landrum, M. J., Lee, J. M., Benson, M., Brown, G. R., Chao, C., Chitipiralla, S., Gu, B., Hart, J., Hoffman, D., Jang, W., et al. (2018) · Nucleic Acids Research · doi:10.1093/nar/gkx1153 · Cited by 4,196
Accurate classification of BRCA1 variants with saturation genome editing
Findlay, G. M., Daza, R. M., Martin, B., Zhang, M. D., Leith, A. P., Gasperini, M., Janizek, J. D., Huang, X., Starita, L. M., & Shendure, J. (2018) · Nature · doi:10.1038/s41586-018-0461-z · Cited by 843
Ligtenberg, M. J. L., Kuiper, R. P., Chan, T. L., Goossens, M., Hebeda, K. M., Voorendt, M., Lee, T. Y. H., Bodmer, D., Hoenselaar, E., Hendriks-Cornelissen, S. J. B., et al. (2009) · Nature Genetics · doi:10.1038/ng.283 · Cited by 818 · cited 1×
“4%) had a P/LP somatic ‘second hit’ in MSH2, or a structural variant in the upstream gene EPCAM (which causes epigenetic silencing of MSH2 [34,35].”
BackgroundRentzsch, P., Schubach, M., Shendure, J., & Kircher, M. (2021) · Genome Medicine · doi:10.1186/s13073-021-00835-9 · Cited by 640 · cited 1×
“For the purposes of this study, we used predictions from SpliceAI [36], a deep learning-based splicing effect predictor which has been shown to be highly accurate [48].”
MethodModeling the ACMG/AMP variant classification guidelines as a Bayesian classification framework
Tavtigian, S. V., Greenblatt, M. S., Harrison, S. M., Nussbaum, R. L., Prabhu, S. A., Boucher, K. M., & Biesecker, L. G. (2018) · Genetics in Medicine · doi:10.1038/gim.2017.210 · Cited by 590 · cited 2×
“Function scores’ strength of evidence for or against pathogenicity was quantified using the Oddspath score [22,31].”
MethodVariant interpretation: functional assays to the rescue
Starita, L. M., Ahituv, N., Dunham, M. J., Kitzman, J. O., Roth, F. P., Seelig, G., Shendure, J., & Fowler, D. M. (2017) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2017.07.014 · Cited by 381 · cited 1×
“New approaches (collectively termed multiplex assays of variant effect, or MAVEs) have enabled the systematic testing of many variants at a time [17,18].”
BackgroundSelf-citation
Cited by
Rubin, A. F., Stone, J., Bianchi, A. H., Capodanno, B. J., Da, E. Y., Dias, M., Esposito, D., Frazer, J., Fu, Y., Grindstaff, S. B., et al. (2025) · Genome Biology · doi:10.1186/s13059-025-03476-y · Cited by 80
Dawood, M., Fayer, S., Pendyala, S., Post, M., Kalra, D., Patterson, K., Venner, E., Muffley, L. A., Fowler, D. M., Rubin, A. F., et al. (2024) · Genome Medicine · doi:10.1186/s13073-024-01392-7 · Cited by 31
“…and the functional scores were systematically integrated into the guidelines for clinical variant interpretation, MAVE data drove reclassification for 50% in BRCA1 [18], 69% in TP53 , 75% in MSH2 [22], and 93% in DDX3X [23] culminating in return of updated patient test results to providers.”
Rowlands, C. F., Allen, S., Garrett, A., Durkie, M., Burghel, G. J., Robinson, R., Callaway, A., Field, J., Frugtniet, B., Palmer-Smith, S., et al. (2025) · The American Journal of Human Genetics · doi:10.1016/j.ajhg.2025.08.014 · Cited by 6
Metadata
- Authors
- Scott, A., Hernandez, F., Chamberlin, A., Smith, C., Karam, R., & Kitzman, J. O.
- Venue
- Genome Biology
- Published
- 2022-12-22
- Volume
- 23
- Issue
- 1
- Pages
- 266-266
- ISSN
- 1465-6906 (ISSN-L)
- 1474-760X
- OpenAlex
- W4312190539
- Cited by
- 35
- References
- 7
- FWCI
- 3.90
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome. https://app.cochat.ai/papers/10.1186/s13059-022-02839-z
- The paper
- Scott, A., Hernandez, F., Chamberlin, A., Smith, C., Karam, R., & Kitzman, J. O. (2022). Saturation-scale functional evidence supports clinical variant interpretation in Lynch syndrome. Genome Biology. https://doi.org/10.1186/s13059-022-02839-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.